Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.

Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG.

J Biol Chem. 2013 Mar 22;288(12):8679-90. doi: 10.1074/jbc.M112.409672. Epub 2013 Jan 18.

2.

Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.

Cerboni C, Mousavi-Jazi M, Wakiguchi H, Carbone E, Kärre K, Söderström K.

Eur J Immunol. 2001 Oct;31(10):2926-35.

PMID:
11592068
3.

CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.

Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, Huyton T, Heroux A, Hoare HL, Beddoe T, Reid HH, Wilce MC, Brooks AG, Rossjohn J.

J Exp Med. 2008 Mar 17;205(3):725-35. doi: 10.1084/jem.20072525. Epub 2008 Mar 10.

5.

Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.

Brooks AG, Borrego F, Posch PE, Patamawenu A, Scorzelli CJ, Ulbrecht M, Weiss EH, Coligan JE.

J Immunol. 1999 Jan 1;162(1):305-13.

6.

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ.

Nature. 1998 Feb 19;391(6669):795-9.

PMID:
9486650
7.

Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.

Valés-Gómez M, Reyburn HT, Erskine RA, López-Botet M, Strominger JL.

EMBO J. 1999 Aug 2;18(15):4250-60.

8.

Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.

Ulbrecht M, Martinozzi S, Grzeschik M, Hengel H, Ellwart JW, Pla M, Weiss EH.

J Immunol. 2000 May 15;164(10):5019-22.

9.

Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.

Hoare HL, Sullivan LC, Clements CS, Ely LK, Beddoe T, Henderson KN, Lin J, Reid HH, Brooks AG, Rossjohn J.

J Mol Biol. 2008 Apr 11;377(5):1297-303. doi: 10.1016/j.jmb.2008.01.098. Epub 2008 Feb 12. Review.

PMID:
18339401
10.

Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.

Miller JD, Weber DA, Ibegbu C, Pohl J, Altman JD, Jensen PE.

J Immunol. 2003 Aug 1;171(3):1369-75.

11.

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

Gumá M, Budt M, Sáez A, Brckalo T, Hengel H, Angulo A, López-Botet M.

Blood. 2006 May 1;107(9):3624-31. Epub 2005 Dec 29.

12.

The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.

Sullivan LC, Westall GP, Widjaja JM, Mifsud NA, Nguyen TH, Meehan AC, Kotsimbos TC, Brooks AG.

PLoS One. 2015 Aug 24;10(8):e0135972. doi: 10.1371/journal.pone.0135972. eCollection 2015.

13.

HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.

Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A.

Eur J Immunol. 1997 Aug;27(8):1875-80.

PMID:
9295021
14.

Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?

Gong F, Song S, Lv G, Pan Y, Zhang D, Jiang H.

Acta Biochim Biophys Sin (Shanghai). 2012 Jul;44(7):551-4. doi: 10.1093/abbs/gms032. Epub 2012 May 9. Review.

PMID:
22576308
16.

HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.

Llano M, Lee N, Navarro F, García P, Albar JP, Geraghty DE, López-Botet M.

Eur J Immunol. 1998 Sep;28(9):2854-63.

17.

Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.

Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P, Santoni A.

Fertil Steril. 2008 May;89(5 Suppl):1490-6. Epub 2007 Aug 13.

PMID:
17706207
18.

Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.

Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L.

Eur J Immunol. 1997 Jun;27(6):1374-80.

PMID:
9209487
19.

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GW.

Science. 2000 Feb 11;287(5455):1031.

20.

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.

King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM.

Eur J Immunol. 2000 Jun;30(6):1623-31.

Supplemental Content

Support Center